Skip to main content
Premium Trial:

Request an Annual Quote

Rules-Based Medicine Gets Award to Develop Cancer Biomarker Assays

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rules-Based Medicine today said it has received an award for about $3 million to fund the research and development of more than double the number of cancer-associated biomarker assays in its new OncologyMap product.

The funding is a Company Commercialization Award from the Cancer Prevention and Research Institute of Texas and will go toward a three-year plan to develop and validate multiplexed immunoassays that measure 150 to 180 blood-based biomarkers that the National Cancer Institute believes may be associated with cancer, RBM said in a statement. As a result of the work being carried out with the award, the firm believes the resulting product will include the largest number of quantitative immunoassays available for discovering and validating new diagnostic, prognostic, and companion diagnostic tests for cancer.

Austin, Texas-based RBM said in a statement that its Multi Analyte Profiling technology offers researchers "broad, cost-effective" protein analyses in multiples species from a small sample volume.

The company filed a registration statement with the US Securities Exchange Commission for an initial public offering of its common stock in December.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.